In vitro effects of fluticasone propionate
on IL-13 production by mitogen-stimulated lymphocytes

In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytes

Background: Corticosteroid administration produces multiple immunomodulatory effects, including down-regulation of cytokine production by CD4 T lymphocytes. Fluticasone propionate (FP) (Glaxo Smith&Kline, Greenford, UK), a highly lipophilic topical corticosteroid, has been shown to be safe and e...

Full description

Bibliographic Details
Main Authors:	Gabriele Di Lorenzo, Maria Luisa Pacor, Maria Esposito Pellitteri, Sebastiano Gangemi, Patrizia Di Blasi, Giuseppina Candore, Alfredo Colombo, Domenico Lio, Calogero Caruso
Format:	Article
Language:	English
Published:	Hindawi Limited 2002-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1080/09622935020138226

Similar Items

Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
by: Yoxall Sally, et al.
Published: (2007-07-01)

Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
by: Harsha H Kariyawasam, et al.
Published: (2010-06-01)

Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01)

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
by: Xiaofen Jin, et al.
Published: (2020-01-01)

Fluticasone propionate raises IOP in susceptible individuals
by: Sihota Ramanjit, et al.
Published: (2004-01-01)

The efficacy of fluticasone propionate nebulizer therapy in children with laryngotracheitis
by: Лариса Михайлівна Станіславчук
Published: (2015-08-01)

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010-02-01)

Degradation rates and products of fluticasone propionate in alkaline solutions
by: Tadakazu Tokumura, et al.
Published: (2017-10-01)

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
by: Woodcock Ashley, et al.
Published: (2007-09-01)

Fluticasone propionate for external use: pharmacological properties and clinical effectiveness
by: E. V. Dvoriankova
Published: (2021-06-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
by: Belchamber KBR, et al.
Published: (2018-09-01)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
by: Sohal SS
Published: (2017-12-01)

Montelukast added to fluticasone propionate does not alter inflammation or outcomes
by: Djukanović, Ratko, et al.
Published: (2010)

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
by: Nina Maria Ainali, et al.
Published: (2020-08-01)

Efficacy of fluticasone propionate ointment 0.005% in childhood lichen planus
by: Abhinav Kumar, et al.
Published: (2020-01-01)

Inhaled fluticasone propionate impairs pulmonary clearance of <it>Klebsiella Pneumoniae</it> in mice
by: Patterson Craig M, et al.
Published: (2012-05-01)

Preparation of nanosized Fluticasone Propionate nasal spray with improved stability and uniformity
by: Dai Jiajia, et al.
Published: (2015-01-01)

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
by: Barbara P Yawn, et al.
Published: (2010-06-01)

Nongenomic Effects of Fluticasone Propionate and Budesonide on Human Airway Anion Secretion
by: Hasegawa, Yoshinori, et al.
Published: (2012)

Fluticasone propionate/formoterol for COPD management: a randomized controlled trial
by: Papi A, et al.
Published: (2017-07-01)

Comparative Study of Topical Treatment in Allergic Rhinitis Using Azelastine and Fluticasone in a Combination Verses Fluticasone Propionate Alone
by: Raisha G. Dalvi, et al.
Published: (2019-04-01)

Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
by: Marina G. Dogbe, et al.
Published: (2019-10-01)

Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells
by: Berger WE, et al.
Published: (2020-05-01)

Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells.
by: Melanie Manetsch, et al.
Published: (2013-01-01)

Comparison of Effectiveness in Ciclesonide and Fluticasone Propionate on Small Airway Function in Mild Asthma
by: Makoto Hoshino
Published: (2010-01-01)

Lost in the Mist: Acute Adrenal Crisis Following Intranasal Fluticasone Propionate Overuse
by: Arturo Loaiza-Bonilla, et al.
Published: (2010-01-01)

Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01)

Polyaspartamide-Based Nanoparticles Loaded with Fluticasone Propionate and the In Vitro Evaluation towards Cigarette Smoke Effects
by: Emanuela Fabiola Craparo, et al.
Published: (2017-08-01)

Comparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma
by: Akefeh. Ahmadiafshar, et al.
Published: (2010-01-01)

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
by: Hideki Yasui, et al.
Published: (2018-05-01)

Effects of Salmeterol Xinafoate and Fluticasone Propionate on Immunological Activation of Human Cultured Mast Cells
by: Hirotomo Akabane, et al.
Published: (2006-01-01)

The Clinical Evaluation of the Acceptance of Fluticasone Propionate Diskus® by Older Japanese Patients with Bronchial Asthma
by: Hiroyuki Ohbayashi
Published: (2005-01-01)

Beneficial Immunomodulatory Effects of Fluticasone Propionate in <i>Chlamydia pneumoniae</i>-Infected Mice
by: Dóra Paróczai, et al.
Published: (2021-03-01)

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate.
by: Karin A Provost, et al.
Published: (2019-01-01)

Secondary Adrenal Insufficiency Due to the Co-Administration of Ritonavir and Inhaled Fluticasone Propionate : Case report
by: Ali Al-Maqbali, et al.
Published: (2017-08-01)

Crystal structure of fluticasone propionate, C25H31F3O5S
by: Čejka J., et al.
Published: (2005-04-01)

Supercritical CO<sub>2</sub> Extraction of Organic Solvents from Flunisolide and Fluticasone Propionate
by: Lucia Baldino, et al.
Published: (2021-04-01)

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
by: Jordi Roca-Ferrer, et al.
Published: (2018-12-01)

Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database
by: Ryo Atsuta, et al.
Published: (2018-10-01)